Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis
Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed...
Gespeichert in:
Veröffentlicht in: | Internal Medicine 2016/06/15, Vol.55(12), pp.1661-1665 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1665 |
---|---|
container_issue | 12 |
container_start_page | 1661 |
container_title | Internal Medicine |
container_volume | 55 |
creator | Kikuchi, Jun Kaneko, Yuko Kasahara, Hidenori Emoto, Katsura Kubo, Akiharu Okamoto, Shinichiro Takeuchi, Tsutomu |
description | Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder. |
doi_str_mv | 10.2169/internalmedicine.55.6943 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808616206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1797537363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</originalsourceid><addsrcrecordid>eNqFkUtP4zAQx60VaFseXwH5yCXFj9hJjoDYBakIhHbP1sSZNEZ5FNthl29PqpYeEBKXmZHmN88_IZSzheC6uHB9RN9D22HlrOtxodRCF6n8QeZcpkWSCakOyJwVPE_EZGbkKIRnxmSeFeInmYlMMq5EOiflPcZmiB7_Q8QEQhism6KK3vXRwysEO7bg6RL8CulVYrFt6fKtWzdDB9T1FOgjRId9pP9cbOhTg2MHcXAVvfSx8S66cEIOa2gDnu78Mfn76-bP9W2yfPh9d325TKzSLCZpLRUiF1JiqXLFkOep4oW2vKpFmpaVrnVl2cQKFGVZ2BQ5gyqbbpKCCyWPyfm279oPLyOGaDoXNgtDj8MYDM9ZrrkWTH-PZkWmZCa1nNB8i1o_hOCxNmvvOvBvhjOzEcN8FsMoZTZiTKVnuyljOSX3hR_fn4CHLfAcIqxwD4CPzrb4ZWcuNnY3Yk_aBrzBXr4DRvyoWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1797537363</pqid></control><display><type>article</type><title>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</title><source>J-STAGE Free</source><source>MEDLINE</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Kikuchi, Jun ; Kaneko, Yuko ; Kasahara, Hidenori ; Emoto, Katsura ; Kubo, Akiharu ; Okamoto, Shinichiro ; Takeuchi, Tsutomu</creator><creatorcontrib>Kikuchi, Jun ; Kaneko, Yuko ; Kasahara, Hidenori ; Emoto, Katsura ; Kubo, Akiharu ; Okamoto, Shinichiro ; Takeuchi, Tsutomu</creatorcontrib><description>Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.55.6943</identifier><identifier>PMID: 27301524</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Arthritis, Rheumatoid - drug therapy ; Female ; Humans ; intravascular lymphoma ; Japan ; Lymphoma, B-Cell - chemically induced ; Lymphoma, B-Cell - drug therapy ; Lymphoma, Large B-Cell, Diffuse - chemically induced ; Lymphoma, Large B-Cell, Diffuse - drug therapy ; Lymphoproliferative Disorders - chemically induced ; Lymphoproliferative Disorders - drug therapy ; methotrexate ; Methotrexate - adverse effects ; Methotrexate - therapeutic use ; Middle Aged ; Remission Induction ; rheumatoid arthritis ; spontaneous regression</subject><ispartof>Internal Medicine, 2016/06/15, Vol.55(12), pp.1661-1665</ispartof><rights>2016 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</citedby><cites>FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27301524$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kikuchi, Jun</creatorcontrib><creatorcontrib>Kaneko, Yuko</creatorcontrib><creatorcontrib>Kasahara, Hidenori</creatorcontrib><creatorcontrib>Emoto, Katsura</creatorcontrib><creatorcontrib>Kubo, Akiharu</creatorcontrib><creatorcontrib>Okamoto, Shinichiro</creatorcontrib><creatorcontrib>Takeuchi, Tsutomu</creatorcontrib><title>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.</description><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>intravascular lymphoma</subject><subject>Japan</subject><subject>Lymphoma, B-Cell - chemically induced</subject><subject>Lymphoma, B-Cell - drug therapy</subject><subject>Lymphoma, Large B-Cell, Diffuse - chemically induced</subject><subject>Lymphoma, Large B-Cell, Diffuse - drug therapy</subject><subject>Lymphoproliferative Disorders - chemically induced</subject><subject>Lymphoproliferative Disorders - drug therapy</subject><subject>methotrexate</subject><subject>Methotrexate - adverse effects</subject><subject>Methotrexate - therapeutic use</subject><subject>Middle Aged</subject><subject>Remission Induction</subject><subject>rheumatoid arthritis</subject><subject>spontaneous regression</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtP4zAQx60VaFseXwH5yCXFj9hJjoDYBakIhHbP1sSZNEZ5FNthl29PqpYeEBKXmZHmN88_IZSzheC6uHB9RN9D22HlrOtxodRCF6n8QeZcpkWSCakOyJwVPE_EZGbkKIRnxmSeFeInmYlMMq5EOiflPcZmiB7_Q8QEQhism6KK3vXRwysEO7bg6RL8CulVYrFt6fKtWzdDB9T1FOgjRId9pP9cbOhTg2MHcXAVvfSx8S66cEIOa2gDnu78Mfn76-bP9W2yfPh9d325TKzSLCZpLRUiF1JiqXLFkOep4oW2vKpFmpaVrnVl2cQKFGVZ2BQ5gyqbbpKCCyWPyfm279oPLyOGaDoXNgtDj8MYDM9ZrrkWTH-PZkWmZCa1nNB8i1o_hOCxNmvvOvBvhjOzEcN8FsMoZTZiTKVnuyljOSX3hR_fn4CHLfAcIqxwD4CPzrb4ZWcuNnY3Yk_aBrzBXr4DRvyoWw</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Kikuchi, Jun</creator><creator>Kaneko, Yuko</creator><creator>Kasahara, Hidenori</creator><creator>Emoto, Katsura</creator><creator>Kubo, Akiharu</creator><creator>Okamoto, Shinichiro</creator><creator>Takeuchi, Tsutomu</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20160101</creationdate><title>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</title><author>Kikuchi, Jun ; Kaneko, Yuko ; Kasahara, Hidenori ; Emoto, Katsura ; Kubo, Akiharu ; Okamoto, Shinichiro ; Takeuchi, Tsutomu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>intravascular lymphoma</topic><topic>Japan</topic><topic>Lymphoma, B-Cell - chemically induced</topic><topic>Lymphoma, B-Cell - drug therapy</topic><topic>Lymphoma, Large B-Cell, Diffuse - chemically induced</topic><topic>Lymphoma, Large B-Cell, Diffuse - drug therapy</topic><topic>Lymphoproliferative Disorders - chemically induced</topic><topic>Lymphoproliferative Disorders - drug therapy</topic><topic>methotrexate</topic><topic>Methotrexate - adverse effects</topic><topic>Methotrexate - therapeutic use</topic><topic>Middle Aged</topic><topic>Remission Induction</topic><topic>rheumatoid arthritis</topic><topic>spontaneous regression</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kikuchi, Jun</creatorcontrib><creatorcontrib>Kaneko, Yuko</creatorcontrib><creatorcontrib>Kasahara, Hidenori</creatorcontrib><creatorcontrib>Emoto, Katsura</creatorcontrib><creatorcontrib>Kubo, Akiharu</creatorcontrib><creatorcontrib>Okamoto, Shinichiro</creatorcontrib><creatorcontrib>Takeuchi, Tsutomu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kikuchi, Jun</au><au>Kaneko, Yuko</au><au>Kasahara, Hidenori</au><au>Emoto, Katsura</au><au>Kubo, Akiharu</au><au>Okamoto, Shinichiro</au><au>Takeuchi, Tsutomu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>55</volume><issue>12</issue><spage>1661</spage><epage>1665</epage><pages>1661-1665</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>27301524</pmid><doi>10.2169/internalmedicine.55.6943</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-2918 |
ispartof | Internal Medicine, 2016/06/15, Vol.55(12), pp.1661-1665 |
issn | 0918-2918 1349-7235 |
language | eng |
recordid | cdi_proquest_miscellaneous_1808616206 |
source | J-STAGE Free; MEDLINE; PubMed Central Open Access; PubMed Central |
subjects | Arthritis, Rheumatoid - drug therapy Female Humans intravascular lymphoma Japan Lymphoma, B-Cell - chemically induced Lymphoma, B-Cell - drug therapy Lymphoma, Large B-Cell, Diffuse - chemically induced Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoproliferative Disorders - chemically induced Lymphoproliferative Disorders - drug therapy methotrexate Methotrexate - adverse effects Methotrexate - therapeutic use Middle Aged Remission Induction rheumatoid arthritis spontaneous regression |
title | Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methotrexate-associated%20Intravascular%20Large%20B-cell%20Lymphoma%20in%20a%20Patient%20with%20Rheumatoid%20Arthritis&rft.jtitle=Internal%20Medicine&rft.au=Kikuchi,%20Jun&rft.date=2016-01-01&rft.volume=55&rft.issue=12&rft.spage=1661&rft.epage=1665&rft.pages=1661-1665&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.55.6943&rft_dat=%3Cproquest_cross%3E1797537363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1797537363&rft_id=info:pmid/27301524&rfr_iscdi=true |